Table 5.
Univariable analysis of risk factors for proteinuria (PRO)
| N | PRO (N) |
OR | 95% CI | p | ||
|---|---|---|---|---|---|---|
| Age (1 year increment) | 0.9 | 0.9-1.0 | 0.12 | |||
| Gender | Male | 67 | 5 | 1 | ||
| Female | 173 | 10 | 0.8 | 0.2-2.3 | 0.63 | |
| CD4 (1 cell/mm3 increment) | 0.9 | 0.9-1.0 | 0.44 | |||
| Hepatitis B positive | No | 215 | 14 | 1 | ||
| Yes | 12 | 1 | 0.8 | 0.1-6.3 | 0.80 | |
| Hepatitis C positive | No | 213 | 14 | 1 | ||
| Yes | 13 | 1 | 0.8 | 0.1-7.0 | 0.87 | |
| Current HAART | No | 67 | 8 | 1 | ||
| Yes | 171 | 7 | 0.3 | 0.1-0.9 | 0.03 | |
| Viral load (log10 copies/ml) | < 1.6 | 122 | 3 | 1 | ||
| [1.6-3.3] | 59 | 4 | 2.9 | 0.6-13.3 | ||
| [3.3-3.8] | 49 | 8 | 7.7 | 1.9-30.6 | < 0.01 |
PRO, Proteinuria; OR, Odds Ratio, 95% CI, 95% Confidence Interval, HAART, Highly Active Antiretroviral Therapy